- Home
- EDSA vs FPAY Comparison
EDSA vs FPAY Comparison
Compare EDSA & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- FPAY
- Stock Information
- Founded
- EDSA 2015
- FPAY 2003
- Country
- EDSA Canada
- FPAY United States
- Employees
- EDSA N/A
- FPAY N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- FPAY Diversified Commercial Services
- Sector
- EDSA Health Care
- FPAY Consumer Discretionary
- Exchange
- EDSA Nasdaq
- FPAY Nasdaq
- Market Cap
- EDSA 17.2M
- FPAY 18.3M
- IPO Year
- EDSA N/A
- FPAY N/A
- Fundamental
- Price
- EDSA $2.39
- FPAY $0.78
- Analyst Decision
- EDSA Strong Buy
- FPAY Strong Buy
- Analyst Count
- EDSA 2
- FPAY 2
- Target Price
- EDSA $13.00
- FPAY $3.25
- AVG Volume (30 Days)
- EDSA 11.7K
- FPAY 186.0K
- Earning Date
- EDSA 08-08-2025
- FPAY 11-12-2025
- Dividend Yield
- EDSA N/A
- FPAY N/A
- EPS Growth
- EDSA N/A
- FPAY N/A
- EPS
- EDSA N/A
- FPAY N/A
- Revenue
- EDSA N/A
- FPAY $139,800,732.00
- Revenue This Year
- EDSA N/A
- FPAY $19.71
- Revenue Next Year
- EDSA N/A
- FPAY N/A
- P/E Ratio
- EDSA N/A
- FPAY N/A
- Revenue Growth
- EDSA N/A
- FPAY 19.51
- 52 Week Low
- EDSA $1.55
- FPAY $0.45
- 52 Week High
- EDSA $5.00
- FPAY $2.37
- Technical
- Relative Strength Index (RSI)
- EDSA 51.55
- FPAY 52.64
- Support Level
- EDSA $2.41
- FPAY $0.66
- Resistance Level
- EDSA $2.47
- FPAY $0.98
- Average True Range (ATR)
- EDSA 0.09
- FPAY 0.08
- MACD
- EDSA -0.01
- FPAY 0.03
- Stochastic Oscillator
- EDSA 48.15
- FPAY 46.11
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.